 |
| |
| |
| |
| |
| |
| |
|
| TissGeneSummary for C4B |
 Gene summary |
| Basic gene information | Gene symbol | C4B |
| Gene name | ||
| Synonyms | ||
| Cytomap | UCSC genome browser: | |
| Type of gene | ||
| RefGenes | ||
| Description | ||
| Modification date | ||
| dbXrefs | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_C4B | |
| BioGPS: 100293534 | ||
| Pathway | NCI Pathway Interaction Database: C4B | |
| KEGG: C4B | ||
| REACTOME: C4B | ||
| Pathway Commons: C4B | ||
| Context | iHOP: C4B | |
| ligand binding site mutation search in PubMed: C4B | ||
| UCL Cancer Institute: C4B | ||
| Assigned class in TissGDB* | C | |
| Included tissue-specific gene expression resources | TiGER,GTEx | |
| Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Liver | |
| Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | LIHC | |
| Reference showing the relevant tissue of C4B | ||
| Description by TissGene annotations | ||
| * Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO term | PubMed ID |
| Top |
| TissGeneExp for C4B |
| Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
| Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
 |
| Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
 |
| Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
| - Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
| Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
| Top |
| TissGene-miRNA for C4B |
| Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
| Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
| Top |
| TissGeneMut for C4B |
| TissGeneSNV for C4B |
| nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
 |
 |
| Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
 |
| - nsSNVs sorted by frequency. |
| AAchange | Cancer type | # samples |
| p.D1208N | SKCM | 2 |
| p.S1116L | SKCM | 2 |
| p.D1073G | KICH | 1 |
| p.R1055W | BLCA | 1 |
| p.T1196M | LUAD | 1 |
| p.G1372V | BRCA | 1 |
| p.G1073D | LIHC | 1 |
| p.G1186R | SKCM | 1 |
| p.G1073D | ESCA | 1 |
| p.R1291C | HNSC | 1 |
| p.Q1303* | SKCM | 1 |
| p.G1073D | BLCA | 1 |
| p.A1068V | LGG | 1 |
| p.G1298E | SKCM | 1 |
| p.H1275P | LIHC | 1 |
| p.S1173* | LUSC | 1 |
| p.E1223K | HNSC | 1 |
| p.Y1198C | LUSC | 1 |
| p.G1073D | HNSC | 1 |
| p.H1275Y | SKCM | 1 |
| p.P1206S | SKCM | 1 |
| p.S1116L | LUAD | 1 |
| p.V889M | KIRP | 1 |
| p.P1122S | SKCM | 1 |
| p.R916Q | BLCA | 1 |
| p.G1073D | CESC | 1 |
| p.Q1118* | SKCM | 1 |
| p.S1232L | CESC | 1 |
| p.Q1292* | SKCM | 1 |
| Top |
| TissGeneCNV for C4B |
| Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
 |
| Top |
| TissGeneFusions for C4B |
| Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
| Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
| Top |
| TissGeneNet for C4B |
| Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
| Top |
| TissGeneProg for C4B |
| Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
| Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
| Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
| Top |
| TissGeneClin for C4B |
| TissGeneDrug for C4B |
| Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
| DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Top |
| TissGeneDisease for C4B |
| Disease information associated with TissGene (DisGeNet, 2016-06-01) |
| Disease ID | Disease name | # pubmeds | Source |
| umls:C0024141 | Lupus Erythematosus, Systemic | 21 | BeFree,GAD,LHGDN,MGD |
| umls:C0011854 | Diabetes Mellitus, Insulin-Dependent | 7 | BeFree |
| umls:C0003873 | Rheumatoid Arthritis | 6 | BeFree |
| umls:C0004352 | Autistic Disorder | 6 | BeFree,CTD_human,GAD |
| umls:C0004364 | Autoimmune Diseases | 6 | BeFree,CTD_human,GAD,LHGDN |
| umls:C0033626 | Protein Deficiency | 5 | BeFree |
| umls:C0001627 | Congenital adrenal hyperplasia | 4 | BeFree,GAD |
| umls:C0002395 | Alzheimer's Disease | 4 | BeFree,GAD |
| umls:C2936858 | Congenital adrenal hyperplasia due to 21 hydroxylase deficiency | 4 | BeFree |
| umls:C3280642 | Complement Component 4a Deficiency | 4 | BeFree |
| umls:C0007222 | Cardiovascular Diseases | 3 | BeFree |
| umls:C0027051 | Myocardial Infarction | 3 | BeFree,LHGDN |
| umls:C0038644 | Sudden infant death syndrome | 3 | BeFree |
| umls:C0155765 | Disease of capillaries | 3 | BeFree |
| umls:C0852654 | 21-hydroxylase deficiency | 3 | BeFree |
| umls:C0008312 | Primary biliary cirrhosis | 2 | BeFree |
| umls:C0011265 | Presenile dementia | 2 | BeFree |
| umls:C0017658 | Glomerulonephritis | 2 | BeFree |
| umls:C0018213 | Graves Disease | 2 | BeFree |
| umls:C0024131 | Lupus Vulgaris | 2 | BeFree |
| umls:C0024138 | Lupus Erythematosus, Discoid | 2 | BeFree |
| umls:C0033860 | Psoriasis | 2 | BeFree,LHGDN |
| umls:C0038454 | Cerebrovascular accident | 2 | BeFree,LHGDN |
| umls:C0039263 | Takayasu Arteritis | 2 | BeFree |
| umls:C0155626 | Acute myocardial infarction | 2 | BeFree |
| umls:C0162538 | Immunoglobulin A deficiency (disorder) | 2 | BeFree |
| umls:C0409974 | Lupus Erythematosus | 2 | BeFree |
| umls:C0497327 | Dementia | 2 | BeFree |
| umls:C1263846 | Attention deficit hyperactivity disorder | 2 | BeFree |
| umls:C3280641 | COMPLEMENT COMPONENT 4B DEFICIENCY | 2 | BeFree |
| umls:C0003864 | Arthritis | 1 | LHGDN |
| umls:C0011609 | Drug Eruptions | 1 | CTD_human |
| umls:C0011847 | Diabetes | 1 | BeFree |
| umls:C0011849 | Diabetes Mellitus | 1 | BeFree |
| umls:C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 1 | BeFree |
| umls:C0021053 | Immune System Diseases | 1 | BeFree |
| umls:C0021368 | Inflammation | 1 | LHGDN |
| umls:C0023903 | Liver neoplasms | 1 | BeFree |
| umls:C0024140 | Lupus Erythematosus, Subacute Cutaneous | 1 | BeFree |
| umls:C0029118 | Opportunistic Infections | 1 | GAD |
| umls:C0029408 | Degenerative polyarthritis | 1 | BeFree |
| umls:C0034150 | Purpura | 1 | LHGDN |
| umls:C0037116 | Silicosis | 1 | BeFree |
| umls:C0040053 | Thrombosis | 1 | LHGDN |
| umls:C0042900 | Vitiligo | 1 | BeFree |
| umls:C0085437 | Meningitis, Bacterial | 1 | GAD |
| umls:C0086445 | Idiopathic Membranous Glomerulonephritis | 1 | BeFree |
| umls:C0241910 | Hepatitis, Autoimmune | 1 | BeFree |
| umls:C0266929 | Chronic Periodontitis | 1 | LHGDN |
| umls:C0342464 | Salt-losing congenital adrenal hyperplasia | 1 | BeFree |
| umls:C1527336 | Sjogren's Syndrome | 1 | BeFree |
| umls:C1847835 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | 1 | BeFree |
| umls:C2239176 | Liver carcinoma | 1 | BeFree |
| umls:C2609247 | Adrenal incidentaloma | 1 | BeFree |
Copyright 2016-Present - The University of Texas Health Science Center at Houston (UTHealth) Web File Viewing | How to Report, Fraud, Waste and Abuse | State of Texas | Statewide Search | Texas Homeland Security | Site Policies |